Rheumatoid Arthritis How can we Improve Remission? â MM1507
Early diagnosis, referral and initiation of disease-modifying antirheumatic drug (DMARD) therapy, along with regular disease monitoring and treating to target, are crucial to give patients with rheumatoid arthritis the best chance of achieving remission.
Modern Medicine â July 2015
Treating Soft Tissue Rheumatic Disorders – MM1403
Treatment of soft tissue rheumatic disorder involves setting realistic patient expectations and judiciously selecting therapy from the many physical, pharmacological and other modalities available, according to the condition and site affected.
Modern Medicine â March 2014
Managing scleroderma: Challenges in primary care – MM1402
Scleroderma is a complex and challenging connective tissue disease that may affect multiple organ systems.
Modern Medicine â February 2014
Soft Tissue Rheumatic Disorders: Aetiology and Diagnosis – MM1402
In soft tissue rheumatic disorders, it is important to distinguish non-inflammatory causes, such as biomechanical abnormalities or tendon changes
with ageing, from inflammatory causes, such as systemic rheumatic or other diseases.
Modern Medicine â February 2014
Biological Therapies for Rheumatoid Arthritis: Non-TNF Inhibitors â MM1306
Non-tumour necrosis factor (non-TNF) inhibitors are highly effective biological therapies that have radically changed how rheumatoid arthritis is managed, helping patients achieve not only disease control but long-term remission.
Modern Medicine â June 2013
